New Covaris Process Enables Accurate, NGSGrade RNA Extraction from FFPE Tissue Samples
December 16, 2014
WOBURN, Mass. -- Covaris, Inc. has introduced the truXTRAC FFPE RNA Kit. This newest innovation from Covaris extracts high quality RNA, suitable for Next Gen Sequencing (NGS), from FFPE tissue samples. NGS-quality is achieved by the use of Covaris' patented Adaptive Focused Acoustics((R)) (AFA) Technology matched with an optimized reagent system. The truXTRAC FFPE RNA [...]
December 16, 2014
Astrotech Corporation (NASDAQ: ASTC) a company that specializes in the commercialization of valuable space and defense technologies for uses in industrial process control, explosives detection, research and healthcare markets, today announced that its Board of Directors has approved a share repurchase program authorizing the company to repurchase up to $5.0 million of its common stock [...]
December 16, 2014
CHELMSFORD, MASSACHUSETTS, USA -— Brooks Life Science Systems, the global leader in automated sample management for drug discovery and biostorage applications and a division of Brooks Automation, Inc. (Nasdaq: BRKS), has announced the introduction of the Brooks Tube AuditorTM 2.0. Tube Auditor is a next-generation system for high-speed, non-contact sample volume and precipitate measurement of [...]
BioTime Appoints Angus C. Russell to Board of Directors
December 15, 2014
ALAMEDA, Calif. -- BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that Angus C. Russell, former Chief Executive Officer of Shire plc, has been appointed to BioTime's Board of Directors. Shire is a leading global specialty biopharmaceutical company. During Mr. Russell's tenure [...]
December 15, 2014
ALAMEDA, Calif. -- BioTime, Inc. (NYSE MKT: BTX) and its subsidiary OncoCyte Corporation today announced that OncoCyte has completed enrollment in the initial clinical study of its urine-based bladder cancer diagnostic test. The study, which involved 100 patients, was conducted in collaboration with investigators in the Department of Pathology, Division of Cytopathology, at a leading [...]
Low Profile 96-well Deep Well Plate
December 15, 2014
Porvair Sciences low profile 96-well deep well plate achieves a storage volume of 1.1ml / well in a height of just 27 mm enabling more plates to be stacked or stored in a given space. Manufactured from extractables-free polypropylene in an ISO 10,000 approved clean room environment - Porvair low profile plates undergo extensive quality [...]
December 15, 2014
PORTLAND, Ore. -- FEI (Nasdaq:FEIC) and Oregon Health & Science University (OHSU) today announced an expansion of their Living Lab for Cell Biology agreement that includes the installation of a complete correlative microscopy workflow in the new Collaborative Life Sciences Building (CLSB) on OHSU's campus. This expansion adds a new instrument, the FEI CorrSightTM, to [...]
Bruker Introduces BioScope Resolve High-Resolution BioAFM System
December 15, 2014
SAN DIEGO -- At the Sixth AFM BioMed Conference, Bruker (NASDAQ: BRKR) today announced the release ofBioScope Resolve™, a biological atomic force microscope (bioAFM) that features the highest resolution imaging and most complete cell mechanics capabilities available for use with an inverted optical microscope (IOM). The system incorporates Bruker’s proprietaryPeakForce Tapping® technology to enable researchers [...]
New Real-Time In Situ Probe-Based Video Microscope from METTLER TOLEDO
December 15, 2014
METTLER TOLEDO is pleased to announce that the next-generation inline PVM tool, ParticleView V19 with PVM technology, is now available. The new in situ probe-based particle vision and measurement tool continuously captures high-resolution images under a wide range of process conditions. ParticleView V19 then automatically prepares a report pairing the most relevant images to data [...]
December 15, 2014
ALAMEDA, Calif. -- BioTime, Inc. (NYSE MKT: BTX) today announced that its subsidiary ES Cell International Pte. Ltd. (“ESI”) and GE Healthcare (GEHC) have signed a set of license agreements through which GEHC received rights to ESI’s stem cell patents and ESI received rights to stem cell patents controlled by GEHC, in both cases for [...]

